Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial. [PDF]
Laiho JE +10 more
europepmc +1 more source
Antiviral Inactivated Vaccines: Looking to the Past to Face the Future-A Narrative Review. [PDF]
Guedes-da-Silva FH +7 more
europepmc +1 more source
Mainstreaming Mistrust: The Shift in US Vaccine Policy Under the Trump Administration. [PDF]
Musa S, Estlund A, Berman MA.
europepmc +1 more source
Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns. [PDF]
Godin A +15 more
europepmc +1 more source
DTaP-induced infantile epileptic spasms syndrome high-risk window: Insights from school-age children. [PDF]
Zhang Q +15 more
europepmc +1 more source
Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines. [PDF]
Snyder J +8 more
europepmc +1 more source
The Pathogenesis and Virulence of the Major Enterovirus Pathogens Associated with Severe Clinical Manifestations: A Comprehensive Review. [PDF]
Liu Y, Maisimu M, Ge Z, Xiao S, Wang H.
europepmc +1 more source
Inequalities in adolescent HPV, Td/IPV and MenACWY vaccination coverage by socio-economic status: an ecological study, England, 2017 to 2024. [PDF]
Alvi MI +4 more
europepmc +1 more source
Research Progress of Microneedles in Vaccine Delivery. [PDF]
Qiao X, Liu D, Pan W, He M, Meng F.
europepmc +1 more source

